BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27415417)

  • 1. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.
    Castillo JJ; Gustine J; Meid K; Dubeau T; Hunter ZR; Treon SP
    Am J Hematol; 2016 Oct; 91(10):1032-5. PubMed ID: 27415417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
    Durot E; Tomowiak C; Michallet AS; Dupuis J; Hivert B; Leprêtre S; Toussaint E; Godet S; Merabet F; Van Den Neste E; Ivanoff S; Roussel X; Zini JM; Regny C; Lemal R; Sutton L; Perrot A; Le Dû K; Kanagaratnam L; Morel P; Leblond V; Delmer A
    Br J Haematol; 2017 Nov; 179(3):439-448. PubMed ID: 28770576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
    Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
    Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
    Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonally related transformation from Waldenström macroglobulinemia to diffuse large B-cell lymphoma with central nervous system involvement at diagnosis: a case report and literature review.
    Chen H; Zhao D; Wang Z; Zhang W; Wang W
    Clin Exp Med; 2023 Dec; 23(8):5473-5476. PubMed ID: 37921873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
    J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.
    Owen RG; Bynoe AG; Varghese A; de Tute RM; Rawstron AC
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):176-9. PubMed ID: 21856554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia.
    Talaulikar D; Tomowiak C; Toussaint E; Morel P; Kapoor P; Castillo JJ; Delmer A; Durot E
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):787-799. PubMed ID: 37246087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
    Treon SP; Gustine J; Xu L; Manning RJ; Tsakmaklis N; Demos M; Meid K; Guerrera ML; Munshi M; Chan G; Chen J; Kofides A; Patterson CJ; Yang G; Liu X; Severns P; Dubeau T; Hunter ZR; Castillo JJ
    Br J Haematol; 2018 Feb; 180(3):374-380. PubMed ID: 29181840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of MYD88
    Zanwar S; Abeykoon JP; Durot E; King R; Perez Burbano GE; Kumar S; Gertz MA; Quinquenel A; Delmer A; Gonsalves W; Cornillet-Lefebvre P; He R; Warsame R; Buadi FK; Novak AJ; Greipp PT; Inwards D; Habermann TM; Micallef I; Go R; Muchtar E; Kourelis T; Dispenzieri A; Lacy MQ; Dingli D; Nowakowski G; Thompson CA; Johnston P; Thanarajasingam G; Bennani NN; Witzig TE; Villasboas J; Leung N; Lin Y; Kyle RA; Rajkumar SV; Ansell SM; Le-Rademacher JG; Kapoor P
    Am J Hematol; 2020 Mar; 95(3):274-281. PubMed ID: 31814157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Waldenstrom macroglobulinemia in transformation.
    Appenzeller P; Leith CP; Foucar K; Scott AA; Bigler CF; Thompson CT
    Am J Dermatopathol; 1999 Apr; 21(2):151-5. PubMed ID: 10218675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diffuse large B-cell lymphoma occurring in a Waldenström macroglobulinemia patient with central nervous system infiltration].
    Hayashi Y; Sata H; Akuta K; Toda J; Kusakabe S; Ueda T; Ueda Y; Fujita J; Tadokoro S; Maeda T; Nishimura J; Shibayama H; Oritani K; Kanakura Y
    Rinsho Ketsueki; 2015 Nov; 56(11):2351-6. PubMed ID: 26666724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone changes in Waldenstrom's macroglobulinemia].
    Novikova EZ; Mokeeva RA
    Probl Gematol Pereliv Krovi; 1980 Apr; 25(4):26-9. PubMed ID: 6770363
    [No Abstract]   [Full Text] [Related]  

  • 16. From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation.
    Jiménez C; Alonso-Álvarez S; Alcoceba M; Ordóñez GR; García-Álvarez M; Prieto-Conde MI; Chillón MC; Balanzategui A; Corral R; Marín LA; Gutiérrez NC; Puig N; Sarasquete ME; González M; García-Sanz R
    Blood Cancer J; 2017 Aug; 7(8):e591. PubMed ID: 28841204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
    Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T
    Bone Marrow Transplant; 2008 Mar; 41(6):591-3. PubMed ID: 18071292
    [No Abstract]   [Full Text] [Related]  

  • 18. Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation?
    Moonim MT; Nasir A; Hubbard J; Ketley N; Fields P
    Int J Surg Pathol; 2017 Jun; 25(4):326-332. PubMed ID: 27913781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
    Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
    Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].
    Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.